by University of East Anglia Credit: Unsplash/CC0 Public Domain Scientists at the University of East Anglia are a step closer to creating a new generation of light-activated cancer treatments. The futuristic-sounding treatment would work by switching on LED lights embedded close to a tumor, which would then activate biotherapeutic drugs. These new treatments would be...
Even before the COVID-19 pandemic, mental health challenges were the leading cause of poor life outcomes in young people. As many as 1 in 5 US children aged 3 to 17 have a mental, emotional, developmental, or behavioral disorder, according to the Centers for Disease Control and Prevention. Now, that crisis has grown. Symptoms of...
By Angus Chen Jan. 14, 2022 MOLLY FERGUSON FOR STAT CAR-T cell therapy has been a boon for treating blood cancers. Since the technology was first brought to the clinic, CAR-T has offered patients months or years of life after they had exhausted all other treatment options and would have died within weeks. “It’s been...
by University of New South Wales Dr. Deborah Burnett, first author of the paper and Conjoint Senior Lecturer at UNSW’s St Vincent’s Clinical School. Credit: Garvan Institute of Medical Research Medical researchers have outlined a strategy to generate future-proofed COVID-19 vaccines that can resist emergent new viral strains. A study led by the Garvan Institute...
RADBOUD UNIVERSITY MEDICAL CENTER Dutch-French research shows that Optical Genome Mapping (OGM) detects abnormalities in chromosomes and DNA very quickly, effectively, and accurately. Sometimes even better than all existing techniques together, as they describe in two proof-of-concept studies published in the American Journal of Human Genetics. This new technique could radically change the existing workflow...
UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE PHILADELPHIA–When researchers from Penn Medicine found that many patients with B-cell acute lymphoblastic leukemia (ALL) treated with the investigational chimeric antigen receptor (CAR) T cell therapy targeting the CD22 antigen didn’t respond, they went back to the drawing board to determine why. They discovered that less is more when it comes to the...
